686 results on '"Algaba, F"'
Search Results
2. Morbilidad acumulada tras la ureteroscopia para el carcinoma urotelial del tracto superior
3. Indicaciones e histología de 489 orquiectomías analizadas según la edad del paciente
4. Indications and histology of 489 orchiectomies analyzed by patient age
5. Determining PD-L1 expression in invasive urothelial carcinoma: Recommendations from the Spanish society of anatomic pathology
6. LA DETERMINACIÓN DE LA EXPRESIÓN DE PD-L1 EN EL CARCINOMA UROTELIAL INFILTRANTE: RECOMENDACIONES DE LA SOCIEDAD ESPAÑOLA DE ANATOMÍA PATOLÓGICA
7. Intraoperative diagnosis of upper tract urothelial carcinoma with ex-vivo confocal laser microscopy during ureteroscopy
8. Systematic biopsies of the upper tract: A tool to improve the diagnostic accuracy of ureteroscopy and characterization of upper tract urothelial cancer
9. En bloc vs. conventional transurethral resection of bladder tumor: Two-year oncological follow-up of a single-center prospective, randomized, controlled, non-inferiority trial
10. RETRACTED: Metastatic Prostate cancer (mPCa) and Homologous Recombination Deficiency (HRD) in daily practice: experience of 6 years in a tertiary hospital.
11. The 1973 WHO and 2004 WHO grading systems are not equal in prediction of survival among stage T1 bladder cancer patients
12. Multiparametric magnetic resonance imaging and prostate cancer: What's new?
13. Resonancia magnética multiparamétrica y cáncer de próstata: ¿qué hay de nuevo?
14. Adipocyte accumulation in corpus cavernosum: First clinical evidence and pathophysiological implications in erectile dysfunction
15. P130 - RETRACTED: Metastatic Prostate cancer (mPCa) and Homologous Recombination Deficiency (HRD) in daily practice: experience of 6 years in a tertiary hospital.
16. The implementation of systematic biopsies in the endoscopic management of upper tract urothelial cancer
17. Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum
18. Questions and answers on prostate multiparameter magnetic resonance imaging: Everything a urologist should know
19. Prognosis of primary papillary Ta-G3 bladder cancer in the non-muscle invasive spectrum
20. Indications and histology of 489 orchiectomies analyzed by patient age
21. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study
22. Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project
23. Energy source comparison in en-bloc resection of bladder tumor: a step to energy indication
24. En-bloc versus conventional transurethral resection of bladder tumors: single-center prospective randomized trial
25. Ex-vivo confocal laser microscopy in the intraoperative evaluation of surgical margins during minimally invasive radical prostatectomy
26. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
27. Focal therapy for prostate cancer. Rationale, indications and selection
28. O3 - Prognosis of primary papillary Ta-G3 bladder cancer in the non-muscle invasive spectrum
29. T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum
30. El periplo de la determinación de la expresión de PD-L1 en el carcinoma urotelial infiltrante
31. Relevance of the clinical–pathological predictive factors in force in chromophobe renal cell cancer
32. EAU Guidelines on testicular cancer: 2011 update
33. Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette-Guerin immunotherapy
34. Department of Surgery, Autonomous University of Barcelona, Barcelona, Spain br
35. Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists
36. Long-term oncological outcomes of bladder carcinoma in situ (CIS) treated with BCG immunotherapy: prognostic implications of 6-month pathological response assessed by a propensity score matching analysis
37. En-bloc versus conventional transurethral resection of bladder tumors: interim analysis of a single-center prospective randomized trial
38. Impact of clinical and pathological subtypes of carcinoma in situ (CIS) of the bladder: lessons learned from long-term follow-up of a series of CIS patients treated with BCG
39. What is the added value of combined core biopsy and fine needle aspiration in the diagnostic process of renal tumours?
40. Long-term oncological outcomes of bladder Carcinoma In Situ (CIS) treated with BCG immunotherapy: Prognostic implications of 6-month pathological response assessed by a propensity score matching analysis
41. Impact of clinical and pathological subtypes of Carcinoma In Situ (CIS) of the bladder: Lessons learned from long-term follow-up of a series of CIS patients treated with BCG
42. Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group
43. Is the pN category in radical cystectomy dependent on the pathologist dissection?
44. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer
45. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
46. Altered gene expression signature of early stages of the germ line supports the pre-meiotic origin of human spermatogenic failure
47. Pseudoneoplastic lesions of the testis and paratesticular structures
48. P119 - Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, non-invasive bladder tumors in 2019?
49. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
50. Prostate-specific antigen as a marker of prostate disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.